Cistanche Supplements Contract Manufacturing

Lock species, extract type, and marker method before comparing unit cost or awarding fill-and-pack work. Commercially realistic pathways are listed below; higher-potency or specialty grades are confirmed by project after supply qualification.

Available Cistanche Extract Specifications

Ratio vs Marker Specs

Ratio alone does not define potency. A “10:1” from one supplier is not automatically equivalent to a “10:1” from another.

For standardized products, review marker compounds and analytical methods together with extraction ratio. Specification selection should match formula positioning, dose, cost target, and regulatory requirements.

Higher marker concentration does not automatically indicate superior finished-product performance. Select the echinacoside band (typically 10%–20%, or customized) based on brand positioning and label math.

Botanical Source Selection

Do not accept a quote that only says “Cistanche extract.” Lock scientific name, plant part, and marker method before artwork or label math.

Ingredient Form Notes

Spec lock sequence for RFQs: species → ingredient form → marker band + HPLC method (with ratio) → powder processing → finished dosage form + packaging

Request Spec / Grade Options · Download Cistanche Spec Sheet

1. Botanical Authentication

Confirm before awarding supply:

• Scientific name (Cistanche tubulosa or Cistanche deserticola)
• Plant part used
• Source / supply pathway
• Identity verification method

Species substitution and vague “Cistanche” labeling create COA conflicts and retailer risk.

2. Active Marker Specification

Confirm:

• Echinacoside level (typical commercial band 10%–20%, or project-customized)
• Acteoside testing if required by your brand story
• Testing method (HPLC)
• Batch-to-batch acceptance range

Headline percentages without method and acceptance criteria are not comparable across suppliers. Higher marker concentration does not automatically indicate superior finished-product performance—match the band to dose, cost, and positioning.

3. Extraction Process

Confirm:

• Extraction solvent pathway
• Concentration/ratio (DER) — treated as a commercial pathway label, not a standalone potency guarantee
• Drying method
• Fit for finished format (capsule fill · drink solubility · granulation)

Process differences change sensory profile, solubility, and format feasibility—even at the same ratio label. For standardized products, review marker compounds and analytical methods together with extraction ratio.

4. Documentation Package

Confirm availability of:

• COA
• Specification sheet
• Heavy metals report
• Microbial report
• Residual solvents / pesticides as required by pathway and market

Documentation readiness determines whether you can launch, export, or pass customer QA—not just whether a sample looks acceptable.

Get Cistanche Procurement Checklist · Ask for Sample COA Pack

Quality Control Behind Every Batch

Raw Material Control

• Supplier qualification
• Botanical identification
• Incoming inspection & quarantine gate

Laboratory Testing

• HPLC active marker analysis (echinacoside / acteoside as scoped)
• Heavy metals
• Microbiology
• Residual solvents/pesticides as required

Documentation Package

• COA
• Specification sheet
• Test reports
• Manufacturing/batch records (project-scoped)

Batch Release Flow

Supplier Qualification
        ↓
Incoming Quarantine
        ↓
Identity Confirmation (species lock)
        ↓
HPLC Marker Assay (as locked)
        ↓
Heavy Metals · Microbiology · Solvents
        ↓
Release to Production / Reject & Investigate
        ↓
Finished Goods Testing → QA COA Release
        ↓
Lot Traceability + Retention Sample

→ Quality Control · How to Read a COA · Global Raw Material Supply Network

Request Incoming QC / COA Sample Pack · Ask About Marker Lock & Dual Sourcing

Develop a market-ready SKU with formula positioning, dosage-form selection, and combination strategy—not fill-and-pack alone.

Formula Positioning

Category framing for finished labels: men’s wellness · healthy aging · adaptogenic formulas · botanical vitality products. Destination counsel should clear final claims.

Dosage Form Selection

Response Targets

Complex stacks and gummies may need extra engineering time.

Manufacturing Specifications for RFQs

Start My Cistanche Project Brief · Get MOQ & Lead Time

Use this checklist in RFQs and audits. Require locked specs and documentation—not vague assurances.

Specialized Cistanche Manufacturing vs. Generic OEM

1. Botanical Identity

Is the quote explicitly Cistanche tubulosa, Cistanche deserticola, or an undefined “Cistanche extract”?

Species is locked on the project specification and identity-checked before production release.

2. Active Compound Testing

Does the supplier provide HPLC testing for echinacoside / acteoside, with method and acceptance range on the COA?

Marker assay pathways are project-scoped and tied to release criteria.

3. Manufacturing Capability

Can the partner manufacture finished OEM / private label products—or only broker bulk extract? Are line capacity and advanced delivery options published?

See dosage-form capacity and advanced systems above (capsule-in-capsule · tablet-in-capsule · beadlet-in-capsule · dual-phase · tablet sustained-release customization). Platform detail: Manufacturing Capacity.

4. Documentation Availability

Are COA, specification sheet, heavy metals, and microbial reports available before commercial approval?

Spec + COA + project-scoped export / quality packs are provided for commercial projects.

5. Production Scalability

Is there a clear path from sample → pilot → commercial batch under the same locked BOM?

Sample development through mass production with reorder matching is supported.

6. Development Support

Will the partner help with formula positioning, dosage-form selection, and combination design?

R&D collaboration is available via the R&D Center for single-hero and multi-ingredient programs.

Get Cistanche Procurement Checklist · Book a Spec Review Call